GRFS
Grifols SA ADR
NASDAQ: GRFS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$7.91
-1.98% today
Updated 2026-04-29
Market cap
$5.38B
P/E ratio
11.46
P/S ratio
0.72x
EPS (TTM)
$0.69
Dividend yield
2.22%
52W range
$7 – $11
Volume
0.8M
Grifols SA ADR (GRFS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $821.68M | $913.67M | $939.57M | $1.18B | $1.66B | $1.89B | $5.81B | $5.63B | $5.84B | $8.45B | $9.60B | $10.13B | $10.92B | $12.48B | $17.45B | $15.27B | $19.23B | $21.23B | $20.99B | $21.41B |
| Cash & equivalents | $22.86M | $26.88M | $5.69M | $6.37M | $249.37M | $239.65M | $340.59M | $473.33M | $708.78M | $1.08B | $1.14B | $895.01M | $886.52M | $1.03B | $832.87M | $579.65M | $655.49M | $549.21M | $529.58M | $979.78M |
| Current assets | $436.29M | $473.29M | $495.53M | $626.60M | $1.00B | $1.14B | $1.93B | $1.93B | $2.14B | $2.91B | $3.09B | $3.12B | $2.95B | $3.48B | $6.02B | $3.16B | $5.51B | $4.69B | $6.13B | $5.73B |
| Total liabilities | $765.74M | $545.32M | $555.40M | $698.96M | $1.08B | $1.18B | $4.14B | $3.75B | $3.73B | $5.79B | $6.30B | $6.40B | $7.29B | $7.78B | $9.75B | $8.55B | $11.92B | $13.25B | $13.48B | $12.80B |
| Current liabilities | $252.41M | $282.76M | $316.58M | $317.54M | $299.04M | $423.13M | $646.08M | $592.87M | $715.30M | $1.08B | $1.05B | $1.07B | $977.99M | $1.26B | $1.53B | $1.34B | $3.47B | $2.02B | $2.33B | $2.16B |
| Long-term debt | — | — | — | — | $1.03B | $896.80M | $3.64B | $3.41B | $3.36B | $4.93B | $4.96B | $4.68B | $5.87B | $6.01B | $6.09B | $5.90B | $6.10B | $8.15B | $8.22B | $8.42B |
| Shareholder equity | $55.83M | $367.94M | $383.19M | $480.03M | $566.37M | $693.04M | $1.66B | $1.88B | $2.10B | $2.66B | $3.30B | $3.72B | $3.63B | $4.23B | $5.41B | $5.11B | $5.52B | $5.65B | $5.37B | $5.88B |
| Retained earnings | $25.56M | $45.39M | — | — | $147.97M | $115.51M | $50.31M | $256.69M | $276.80M | $384.31M | $412.53M | $422.55M | $539.71M | $459.89M | $528.09M | $618.55M | $248.00M | $208.28M | $79.36M | $156.92M |
| Accounts receivable | $158.72M | $188.87M | $200.47M | $231.81M | $252.63M | $282.99M | $528.60M | $441.79M | $462.65M | $608.33M | $477.80M | $528.52M | $385.26M | $401.57M | $528.13M | $383.23M | $434.14M | $774.20M | $692.86M | $1.08B |
| Inventory | $249.54M | $235.47M | $270.66M | $373.10M | $484.46M | $527.87M | $1.03B | $998.64M | $946.91M | $1.19B | $1.43B | $1.64B | $1.63B | $1.95B | $2.63B | $2.00B | $2.26B | $3.24B | $3.48B | $3.56B |
| Goodwill | $117.11M | $150.82M | $150.24M | $158.57M | $174.00M | $189.45M | $1.90B | $1.87B | $1.83B | $3.17B | $3.53B | $3.64B | $4.59B | $5.21B | $6.18B | $5.33B | $6.23B | $7.01B | $6.80B | $7.40B |